Dynamics of Antiphospholipid Syndrome in Patients with Resistant Epilepsy

D. Minchev

doi:10.14748/ssm.v36i0.1898

Dynamics of Antiphospholipid Syndrome in Patients with Resistant Epilepsy

D. Minchev

Abstract

Antiphospholipid syndrome could be related with the autoimmune pathogenetic mechanisms in epilepsy. The study covered 14 patients with resistant epilepsy aged between 2 and 38 years and divided into two groups: with partial epilepsy with or without secondary generalization (10 cases) and with primarily generalized epilepsy (4 cases). The findings from the clinical, immunological (IgG, IgA, IgM, anticardiolipid amd antinuclear antibodies), EEG and CT examinations during one-month period were twofold analyzed. Eight patients in the first group presented with positive aCL antibodies while 5 ones demonstrated a reduction of IgA. The comparison of the high positivity of aCL antibodies in the group with partial and secondary generalized as well as with primarily generalized seizures was confirmed by the high frequency of the epileptic seizures in these patients, the resistance of the epilepsy independently of the therapy with two or even three anticonvulsive drugs of first and second order and the onset of the disease of about two years. There was a parallelism between the focal and generalized EEG changes and the data of prevailing positive aCL and antinuclear antibodies along with low IgA levels

Keywords

Antiphospholipid Syndrome, Resistan Epilepsy, Immunoglobulins

Full Text

References

Angelini, L., T. Granata , F. Zibordi, S. Binneli, G. Zorzi, C. Besana. Partial seizures associated with antiphospholipid antibodies in childhood.- Neuropediatrics, 29, 1998, 249-253.

Antiphospholipid Antibodies in Stroke Study Group (APASS).- Stroke, 21, 1990, 1268-1273.

Bouma, P. A. D . Determining the prognosis of childhood epilepsies by establishing immune abnormalities.- Clin. Neurol. Neurosurg. (Suppl.), 94, 1992, 54-56.

C h apm an , J., M .C o h e n -A rm o n , Y. Shoenfeld, A .D . Korczyn. Antiphospholipid antibodies pemiealize and depolarize brain synaptoneurosomes.- Lupus, 8, 1999, No 2, 127-133.

E rik s so n , K., J. P e lto la , T. K e ran e n , A. M, H a a p a la , M. Koivikko. High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study o f 50 cases.- Epilepsy Res., 46, 2001, 129-137.

G re a v e s , M. Antiphospholipid antibodies and thrombosis.- Lancet, 353, 1999, 1348-1353.

H e rra n z , M. T., G. R iv a r, M. A. Khamashta , K. U. B la s e r, G. R. Hughes. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.- Arthritis Rheum 31, 1994, No 4, 568-571.

J a in , K. K. Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy.- Drug Saf., 5, 1991, 350-360.

L iou, H. H., C. R. Wang, H. C. Chou. Anticardiolipin antisera from lupus patients with seizures reduce GABA receptor-mediated chloride current in snail neurons.- Life Sei., 54, 1994, 119-125.

P a la c e , J, B.Lang, Epilepsy: an autoimmune disease.- J. Neurol. Neurosurg. Psychiat., 69, 2000, 711-714.

P e lto la , J. T., A.M. H a a p a la , J. 1. Iso ja rv i, A. A u v in e n , J. P a lm io , K. L a tv a la , P. K u lm a la , S. L a in e , O. V a a ra la , T. Keranen. Antiphospholipid and antinuclear antibodies in epileptic syndromes and newly onset seizure disorders.- Am. J. Med., 109, 2000, 712-717.

V e rro t, D., M. S a n -M a rc o , C. D ra v e t, P. G en to n , P. D isd ie r, G. B o lla , J .-R . Harle, L. R e y n au d , P .-J . Weiller. Prevalence and signification o f antinuclear and antiphospholipid antibodies in patients with epilepsy. 1997.

DOI: http://dx.doi.org/10.14748/ssm.v36i0.1898

Array

User Guide